Your session is about to expire
← Back to Search
Acceptance and Commitment Therapy for Chronic Pain
N/A
Waitlist Available
Led By Elissa Kolva, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to end of intervention (weeks 1- 8)
Awards & highlights
No Placebo-Only Group
Summary
This trial will help cancer survivors manage chronic pain through Acceptance and Commitment Therapy (ACT) after active cancer treatment.
Who is the study for?
This trial is for cancer survivors aged 18-100 who've been out of active treatment for at least three months, speak English, and are mentally stable. They should have had solid tumor cancers, be free of or have stable chronic disease, and experience moderate to severe pain from their cancer that's lasted over three months.
What is being tested?
The study tests Acceptance and Commitment Therapy (ACT) as a way to manage chronic pain in cancer survivors against the usual treatments they receive. Participants will either receive ACT sessions or continue with their regular care to see which helps more with pain.
What are the potential side effects?
Since ACT involves therapy rather than medication, side effects aren't like those from drugs but may include emotional discomfort or distress due to discussing painful experiences during the therapeutic process.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from baseline to end of intervention (weeks 1- 8)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to end of intervention (weeks 1- 8)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
The Degree of Effectiveness of Acceptance and Commitment Therapy: [Impact]
Secondary study objectives
Number of Participants Who Want to Use Acceptance and Commitment Therapy as a Method for Treating Chronic Pain Post Active Cancer Treatment Active Cancer Treatment
The Ability of Methodological Strategies Used to Monitor and Enhance the Reliability and Validity of ACT: [Fidelity]
The Degree to Which Patients Enjoy Using Acceptance and Commitment Therapy as a Method for Treating Chronic Pain Post Active Cancer Treatment: [Acceptability]
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Acceptance and Commitment TherapyExperimental Treatment1 Intervention
Participants will receive both the ACT intervention and medication management that is given as usual treatment.
Group II: Treatment as UsualActive Control1 Intervention
Treatment as usual will include ongoing provision of usual treatment options for pain management.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acceptance and Commitment Therapy
2010
Completed Phase 1
~1490
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,802 Previous Clinical Trials
2,822,062 Total Patients Enrolled
7 Trials studying Chronic Pain
712 Patients Enrolled for Chronic Pain
Elissa Kolva, PhDPrincipal InvestigatorUniversity of Colorado, Denver
1 Previous Clinical Trials
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have difficulties being part of a group because of things like feeling very nervous in social situations, or being in a group would make it harder for you to get the care you need.My cancer-related pain is moderate to severe, scoring 4 or higher.My pain is not caused by my cancer.I finished my cancer treatment more than 3 months ago.You should not have serious mental illness symptoms like active psychosis or mania.I am between 18 and 100 years old.I have been in pain for at least three months.I have been diagnosed with a brain or central nervous system cancer.My cancer diagnosis was confirmed through a lab test.My cancer is either not detectable or stable without needing immediate treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Acceptance and Commitment Therapy
- Group 2: Treatment as Usual
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger